Skip to content

A Study Comparing Two Oral Liquids Given Before a Small Intestine CT Scan to See Which Gives Better Images and Is More Comfortable for Patients

Comparative outcomes of two neutral oral contrast agents - Mannitol and Polyethylene glycol in CT Enterography : A randomized controlled trial. - ENTERO-MAP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105328
Enrollment
124
Registered
2026-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K638- Other specified diseases of intestine

Interventions

Intervention1: MANNITOL: Oral administration of Mannitol solution as a neutral oral contrast agent for CT Enterography. Participants will receive a standardized volume administered over a fixed time p

Sponsors

DR SALONI GUPTA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: AGE MORE THAN 18 YEARS FOR CT ENTEROGRAPHY WITH SUSPECTED BOWEL DISEASE. AGE MORE THAN 18 YEARS FOR CT ENTEROGRAPHY FOR OTHER INDICATIONS LIKE SUSPECTED OCCULT BLEEDING, DISEASES, ABDOMINAL MASSES, INTRALUMINAL/ MURAL INTESTINAL MASSES LIKE POLYPS, VASCULAR MALFORMATION ETC., WILLING TO GIVE INFORMED CONSENT

Exclusion criteria

Exclusion criteria: 1. COMPLICATED PATIENTS OF SMALL BOWEL DISEASES, METASTASIS AND OTHER EXTRAINTESTINAL PATHOLOGIES 2. PREGNANCY 3. ALLERGY TO MANNITOL OR PEG 4. eGFR LESS THAN 30ml/min/1.73m 5. cardiac issues like systolic BP MORE THAN 170 mm HG AND /OR DIASTOLIC BLOOD PRESSURE MORE THAN 100 mm HG AND/OR BEING HEMODYNAMICALLY UNSTABLE. 6. RECENT ABDOMINAL SURGERY ( LESS THAN 4 WEEKS ) , BOWEL OBSTRUCTION 7. POOR COMPLIANCE

Design outcomes

Primary

MeasureTime frame
COMPARATIVE ASSESSMENT OF IMAGE QUALITY BETWEEN MANNITOL AND PEG AS ORAL CONTRATS AGENTS USING - QUALITATIVE PARAMETERS USING A 5 PONT RADIOLOGICAL SCORING SYSTEM (1-5) ON CORONAL IMAGES FOR JEJUNUM , ILEUM , EVALUATION OF INTESTINAL WALL AND FOLD VISIBILITY, MOTION ARTEFACTS. 2. QUANTITAIVE PARAMETER USING OUTER TO OUTER WALL DIAMETER ( IN CM) AT STANDARD ANATOMICAL LEVELS ON AXIAL CT IMAGES.Timepoint: 18 MONTHS

Secondary

MeasureTime frame
COMPARATIVE ASSESSMENT OF PATIENT TOLERABILITY AND ACCEPTABILITY USING A STANDARD QUESTIONNAIRE : SYMPTOMS LIKE NAUSEA, VOMITING, BLOATING , ABDOMINAL DISCOMFORT, DIARRHOEA ( YES/NO) 2. TASTE 3. EASE OF INGESTION, WILLINGNESS TO RESUSE THE SAME AGENT, PATIENT SATISFACTION (0-10) SCALETimepoint: 18 MONTHS

Countries

India

Contacts

Public ContactDR GITA DEVI

ALL INDIA INSTITUTE OF MEDICAL SCIENCES, VIJAYPUR , DISTRICT-SAMBA , JAMMU

Gita.devi@aiimsjammu.edu.in9872481612

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026